Skip to main content
. 2016 Mar 31;310(11):G906–G919. doi: 10.1152/ajpgi.00345.2015

Fig. 1.

Fig. 1.

Influence of the azoxymethane (AOM)/dextran sulfate sodium (DSS) model on body weights (A), symptom scores (B), mean symptom score data over the course of the study (C), and symptom score-tumor number correlational analysis (D) (n = 8–10/group). Groups not sharing a common letter differ significantly from one another (P ≤ 0.05).